Post by Xaira Therapeutics

The excitement following the launch of X-Cell shows no sign of slowing down as we welcome Rachel Lane PhD to the team as Senior Vice President, Business Development and Operations. Rachel joins Xaira with deep experience across biotech and investing, most recently serving as Chief Business Officer at Belharra Therapeutics, where she led major platform partnerships with Genentech and Sanofi. In her role, Rachel will lead business development strategy and help scale partnerships around our AI-enabled drug discovery platform. Welcome to the team, Rachel! https://lnkd.in/e8HcXN2Y